Our high-definition therapy platform delivers best-in-class selectivity and targeting and is being evaluated in multiple studies.
Our platform provides high-definition interfaces to the spinal cord, brain, and peripheral nerves. We are targeting unmet need in chronic pain management and sensory-motor paralysis where there are few or failed treatments.